WINTON GROUP Ltd acquired a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 901 shares of the company's stock, valued at approximately $270,000.
Several other large investors have also bought and sold shares of the stock. Legacy Investment Solutions LLC acquired a new stake in shares of HCA Healthcare during the third quarter worth $39,000. Whipplewood Advisors LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at about $31,000. Tidemark LLC acquired a new stake in HCA Healthcare during the fourth quarter worth approximately $36,000. Activest Wealth Management boosted its holdings in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after buying an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. increased its stake in shares of HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after acquiring an additional 50 shares in the last quarter. 62.73% of the stock is owned by institutional investors.
HCA Healthcare Trading Up 0.5 %
Shares of HCA stock traded up $1.75 on Wednesday, hitting $347.48. 1,249,318 shares of the company's stock traded hands, compared to its average volume of 1,347,915. The company's fifty day simple moving average is $325.79 and its 200 day simple moving average is $340.25. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The stock has a market capitalization of $85.55 billion, a price-to-earnings ratio of 15.82, a P/E/G ratio of 1.10 and a beta of 1.68.
HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the business earned $5.90 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.
HCA Healthcare Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were given a dividend of $0.72 per share. The ex-dividend date was Monday, March 17th. This represents a $2.88 annualized dividend and a dividend yield of 0.83%. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's payout ratio is currently 13.11%.
Analysts Set New Price Targets
Several research firms have weighed in on HCA. KeyCorp decreased their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a research note on Tuesday, January 7th. Barclays dropped their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research note on Monday, January 27th. JPMorgan Chase & Co. restated a "neutral" rating and issued a $380.00 target price on shares of HCA Healthcare in a report on Tuesday, December 17th. Truist Financial cut their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Finally, Royal Bank of Canada decreased their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $385.67.
Check Out Our Latest Report on HCA
Insiders Place Their Bets
In related news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares of the company's stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is currently owned by company insiders.
About HCA Healthcare
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Read More
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
